...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.
【24h】

Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.

机译:细菌蛋白可以由转运蛋白中的巨噬细胞处理,该转运蛋白与抗原独立的,半胱氨酸蛋白酶依赖的方式相关,以通过MHC I类分子呈递。

获取原文
获取原文并翻译 | 示例

摘要

MHC class I molecules present peptides derived primarily from endogenously synthesized proteins on the cell surface as ligands for CD8+ T cells. However, CD8+ T cell responses to extracellular bacteria, virus-infected, or tumor cells can also be elicited because certain professional APC can generate peptide/MHC class I (MHC-I) complexes from exogenous sources. Whether the peptide/MHC-I complexes are generated because the exogenous proteins enter the classical cytosolic, TAP-dependent MHC-I processing pathway or an alternate pathway is controversial. Here we analyze the generation of peptide/MHC-I complexes from recombinant Escherichia coli as an exogenous Ag source that could be delivered to the phagosomes or directly into the cytosol. We show that peritoneal and bone marrow macrophages generate peptide/MHC-I complexes by the classical as well as an alternate, but relatively less efficient, TAP-independent pathway. Using a novel method to detect proteolytic intermediates we show that the generation of the optimal MHC-I binding peptide in the alternate pathway requires cysteine as well as other protease(s). This alternate TAP-independent pathway also operates in vivo and provides a potential mechanism for eliciting CD8+ T cell responses to exogenous Ags.
机译:MHC I类分子将主要来源于细胞表面内源性合成蛋白的肽作为CD8 + T细胞的配体。但是,也可以引起CD8 + T细胞对细胞外细菌,病毒感染或肿瘤细胞的反应,因为某些专业的APC可以从外源产生肽/ MHC I类(MHC-1)复合物。是否由于外源蛋白进入经典的胞质,依赖TAP的MHC-1加工途径或替代途径而产生了肽/ MHC-1络合物是有争议的。在这里,我们分析了重组大肠杆菌作为外源Ag来源的肽/ MHC-I复合物的产生,可以将其递送至吞噬体或直接递送至细胞质中。我们显示腹膜和骨髓巨噬细胞通过经典的以及替代的但效率相对较低的TAP独立途径产生肽/ MHC-I复合物。使用新颖的方法来检测蛋白水解中间体,我们表明在替代途径中最佳MHC-1结合肽的产生需要半胱氨酸以及其他蛋白酶。该备选的非TAP依赖性途径也在体内起作用,并提供了引发CD8 + T细胞对外源Ag应答的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号